Understanding Myeloid-Derived Suppressor Cells in Cancer
Author Information
Author(s): Melissa G. Lechner, Carolina Megiel, Sarah M. Russell, Brigid Bingham, Tammy Woo, Alan L. Epstein
Primary Institution: USC Keck School of Medicine
Hypothesis
Can human tumor cell lines induce myeloid-derived suppressor cells (MDSC) from peripheral blood mononuclear cells?
Conclusion
The study identifies two distinct subsets of MDSC induced by various human solid tumors, which could inform new cancer therapies.
Supporting Evidence
- 45 out of 101 tumor cell lines induced CD33+ MDSC.
- CD33+ MDSC induction was significantly correlated with the expression of IL-1β, IL-6, TNFα, VEGF, and GM-CSF.
- Breast cancer cell lines did not induce CD33+ MDSC.
- CD11b+ MDSC were induced by FLT3L and TGFβ from certain tumor cell lines.
- Both MDSC subsets showed up-regulation of suppressive genes like ARG-1 and iNOS.
Takeaway
This study shows that certain cancer cells can make special immune cells that help tumors grow by stopping the body's defenses.
Methodology
The study used in vitro co-culture methods to induce MDSC from healthy donor PBMC with various human tumor cell lines.
Potential Biases
Potential bias in selecting tumor cell lines and donor variability.
Limitations
The study primarily focuses on in vitro findings, which may not fully replicate in vivo conditions.
Participant Demographics
39 male and 22 female healthy volunteers aged 23 to 62.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website